Commentary: Nonspecific Protein Binding versus Membrane Partitioning: It Is Not Just Semantics

Nonspecific binding or sequestration results in differences between free and total drug concentrations, both in vitro and in vivo. Membrane partitioning and not protein binding is the primary mechanism of drug sequestration. Therefore, physicochemical properties, e.g., LogP can be used to predict drug sequestration in membrane and cell-based assays. The concentration of drug in a membrane is determined by the both the rate in and out of the membrane. In contrast, membrane permeability is a function of the rate in only. This commentary discusses the origins of membrane partitioning and permeability and their impact on cellular disposition.

[1]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[2]  C. D. Francesco,et al.  Membrane lipids as intracellular binders of chlorpromazine and related drugs. , 1977, Chemico-biological interactions.

[3]  J. Axelrod The enzymatic conversion of codeine to morphine. , 1955, The Journal of pharmacology and experimental therapeutics.

[4]  D. Greenblatt,et al.  Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[5]  M. Bickel,et al.  Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. , 1979, Biochemical pharmacology.

[6]  M. Hennessy,et al.  A primer on the mechanics of P-glycoprotein the multidrug transporter. , 2007, Pharmacological research.

[7]  Ying Zhang,et al.  In Silico Modeling of Nonspecific Binding to Human Liver Microsomes , 2008, Drug Metabolism and Disposition.

[8]  J. Axelrod The enzymatic deamination of amphetamine (benzedrine). , 1955, The Journal of biological chemistry.

[9]  Sagar Agarwal,et al.  Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. , 2011, Current pharmaceutical design.

[10]  I. Pastan,et al.  Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.

[11]  J Brian Houston,et al.  BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT , 2006, Drug Metabolism and Disposition.

[12]  Michael Gertz,et al.  Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data , 2008, Drug Metabolism and Disposition.

[13]  C. de Duve,et al.  A short history of tissue fractionation , 1981, The Journal of cell biology.

[14]  B. Alberts,et al.  Intracellular Compartments and Protein Sorting , 2002 .

[15]  M. Bickel,et al.  Binding of basic and acidic drugs to rat tissue subcellular fractions. , 1974, Chemico-biological interactions.

[16]  R. Austin,et al.  A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES , 2005, Drug Metabolism and Disposition.

[17]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[18]  J. Cooper,et al.  Detoxication of drugs and other foreign compounds by liver microsomes. , 1955, Science.

[19]  I. Hidalgo,et al.  Models to Predict Unbound Intracellular Drug Concentrations in the Presence of Transporters , 2012, Drug Metabolism and Disposition.

[20]  C. Hansch Quantitative approach to biochemical structure-activity relationships , 1969 .

[21]  J. Mönkkönen,et al.  Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  Scott L Cockroft,et al.  The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[23]  H. Waterbeemd,et al.  Pharmacokinetics and Metabolism in Drug Design: SMITH:PHARMACOKINETICS 3E O-BK , 2012 .

[24]  M. Bickel,et al.  Experimental errors resulting from uptake of lipophilic drugs by soft plastic materials. , 1970, Biochemical pharmacology.

[25]  K. Skubitz P-glycoprotein and multidrug resistance. , 1990, American journal of clinical pathology.

[26]  Rebecca C Wade,et al.  The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.

[27]  P. Janmey,et al.  Biophysical properties of lipids and dynamic membranes. , 2006, Trends in cell biology.

[28]  T. Österberg,et al.  Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  L. Benet,et al.  IN VITRO AND IN VIVO CORRELATION OF HEPATIC TRANSPORTER EFFECTS ON ERYTHROMYCIN METABOLISM: CHARACTERIZING THE IMPORTANCE OF TRANSPORTER-ENZYME INTERPLAY , 2006, Drug Metabolism and Disposition.

[30]  P. Siekevitz,et al.  ENZYME-STRUCTURE RELATIONSHIPS IN THE ENDOPLASMIC RETICULUM OF RAT LIVER , 1962, The Journal of cell biology.

[31]  R. Obach,et al.  Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[32]  R. Obach,et al.  Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[33]  K. Pang,et al.  Interplay of transporters and enzymes in the Caco‐2 cell monolayer: I. effect of altered apical secretion , 2010, Biopharmaceutics & drug disposition.

[34]  R. Austin,et al.  The effect of ionized species on microsomal binding. , 2012, European journal of medicinal chemistry.